Pneumococcal vaccine - Active Biotech
Alternative Names: Streptococcus pneumoniae vaccine - Active BiotechLatest Information Update: 24 Oct 2021
At a glance
- Originator Active Biotech
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 24 Jan 2017 Discontinued - Preclinical for Pneumococcal infections in United Kingdom (unspecified route)
- 14 Dec 2000 Actinova has been closed down
- 14 Dec 2000 Suspended-Preclinical for Pneumococcal infections in United Kingdom (Unknown route)